FLUOTAG
Mark Identification

FLUOTAG

Serial Number

87372427

Filing Date

Mar 15, 2017

Registration Date

Apr 10, 2018

Trademark by

NANOTAG BIOTECHNOLOGIES GMBH

Active Trademark

Classification Information

Chemical reagents for scientific or industrial purposes and not for medical or veterinary use, namely, chemical reagents containing antibodies or proteins having antibody-like properties; Chemical reagents for scientific or industrial purposes and not for medical or veterinary use, namely, for microscopy, flow cytometry, western blot, imaging, fluorescence based analysis, or tissue analysis; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents containing antibodies or proteins having antibody-like properties; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents for microscopy, flow cytometry, western blot, imaging, fluorescence based analysis, or tissue analysis

Chemicals

Pharmaceutical and veterinary preparations containing antibodies, all for use in treating cancer; Pharmaceutical and veterinary preparations containing antibodies, all for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing antibodies, all for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing antibodies, all for use in treating inflammatory diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating cancer; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating inflammatory diseases; Diagnostic preparations for medical or veterinary purposes, namely preparations containing antibodies or proteins having antibody-like properties; Drugs being pharmaceutical preparations containing antibodies, all for use in treating cancer; Drugs being pharmaceutical preparations containing antibodies, all for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing antibodies, all for use in treating infectious diseases; Drugs being pharmaceutical preparations containing antibodies, all for use in treating inflammatory diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating cancer; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating infectious diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating inflammatory diseases; Vaccines containing antibodies; Vaccines containing proteins having antibody-like properties

Pharmaceuticals